Skip to main content
. 1999 Jun;97(2):341–347. doi: 10.1046/j.1365-2567.1999.00800.x

Figure 2.

Figure 2

Prelabelling of target cells with Cascade Blue© does not alter NK cell recognition. RNK-16 49A effector cells were assayed for their ability to lyse YB or YB-Dd tumour target cells. The target cells were surface biotinylated and labelled with Cascade Blue© prior to use in 4-hr 51Cr-release assays. The results are representative of three independent experiments.